17-β Estradiol Independently Regulates Erythropoietin Synthesis and NOS Activity during Hypoxia

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 2, 2004, Pages 312-317

  Mukundan, Harshini ^a   Resta, Thomas C ^a   Kanagy, Nancy L ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; N nitro L arginine; Nitric oxide synthase; Polycythemia

Indexed keywords

ERYTHROPOIETIN; ESTRADIOL; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; POLYPROPYLENE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETER; ARTICLE; BOLUS INJECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; HYPOXIA; INTRAVENOUS CATHETER; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANOXIA; BLOOD PRESSURE; ERYTHROPOIETIN; ESTRADIOL; FEMALE; HEART RATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 1642540946     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200402000-00023     Document Type: Article

References (35)

1. Grover RF. Pulmonary circulation in animals and man at high altitude. Ann N Y Acad Sci. 1965;127:632-639.
2. Rubin LJ. In: Weir EK, Reeves JT, eds. Pulmonary Hypertension. New York: Futura Publishing Co., 1984:291-320.
3. Resta TC, Gonzales RJ, Dail WG, et al. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am J Physiol. 1997;272:H806-H813.
4. Mukundan H, Resta TC, Kanagy NL. 17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression. Am J Physiol Regul Integr Comp Physiol. 2002;283:R496-R504.
5. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-5454.
6. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
7. Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103:401-406.
8. Kim HP, Lee JY, Jeong JK, et al. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun. 1999;263:257-262.
9. Sogawa K, Numayama-Tsuruta K, Ema M, et al. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA. 1998;95:7368-7373.
10. Todorov V, Gess B, Godecke A, et al. Endogenous nitric oxide attenuates erythropoietin gene expression in vivo. Pflugers Arch. 2000;439:445-448.
11. Gonzales RJ, Walker BR, Kanagy NL. 17beta-estradiol increases nitric oxide-dependent dilation in rat pulmonary arteries and thoracic aorta. Am J Physiol Lung Cell Mol Physiol. 2001;280:L555-L564.
12. Gonzales RJ, Kanagy NL. Endothelium-Independent Relaxation of Vascular Smooth Muscle by 17beta-Estradiol. J Cardiovasc Pharmacol Ther. 1999;4:227-234.
13. Malin DH, Lake JR, Shenoi M, et al. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat. Psychopharmacology (Berl). 1998;140:371-377.
14. Tozer GM, Prise VE, Chaplin DJ. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res. 1997;57:948-955.
15. Evans MJ, Eckert A, Lai K, et al. Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res. 2001;89:823-830.
16. Lemke SL, Mayura K, Reeves WR, et al. Investigation of organophilic montmorillonite clay inclusion in zearalenone-contaminated diets using the mouse uterine weight bioassay. J Toxicol Environ Health A. 2001;62:243-258.
17. Padilla-Banks E, Jefferson WN, Newbold RR. The immature mouse is a suitable model for detection of estrogenicity in the uterotropic bioassay. Environ Health Perspect. 2001;109:821-826.
18. Ou LC, Sardella GL, Leiter JC, et al. Role of sex hormones in development of chronic mountain sickness in rats. J Appl Physiol. 1994;77:427-433.
19. Resta TC, Kanagy NL, Walker BR. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression. Am J Physiol Lung Cell Mol Physiol. 2001;280:L88-L97.
20. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9:619-626.
21. Tojo A, Kimoto M, Wilcox CS. Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin. Kidney Int. 2000;58:2075-2083.
22. Porst M, Hartner A, Krause H, et al. Inducible nitric oxide synthase and glomerular hemodynamics in rats with liver cirrhosis. Am J Physiol Renal Physiol. 2001;281:F293-F299.
23. Reckelhoff JF, Hennington BS, Moore AG, et al. Gender differences in the renal nitric oxide (NO) system: dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens. 1998;11:97-104.
24. Rupnow HL, Phernetton TM, Shaw CE, et al. Endothelial vasodilator production by uterine and systemic arteries. VII. Estrogen and progesterone effects on eNOS. Am J Physiol Heart Circ Physiol. 2001;280:H1699-H1705.
25. Vagnoni KE, Shaw CE, Phernetton TM, et al. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase. Am J Physiol. 1998;275:H1845-H1856.
26. Semenza GL. Hypoxia-inducible factor 1: control of oxygen homeostasis in health and disease. Pediatr Res. 2001;49:614-617.
27. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem. 1993; 268:21513-21518.
28. Earley S, Resta TC. Estradiol attenuates hypoxia-induced pulmonary endothelin-1 gene expression. Am J Physiol Lung Cell Mol Physiol. 2002;283:L86-L93.
29. Sandau KB, Fandrey J, Brune B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood. 2001;97:1009-1015.
30. Huang LE, Willmore WG, Gu J, et al. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J Biol Chem. 1999;274:9038-9044.
31. Mukundan H, Kanagy NL. Ca2+ influx mediates enhanced alpha2-adrenergic contraction in aortas from rats treated with NOS inhibitor. Am J Physiol Heart Circ Physiol. 2001;281:H2233-H2240.
32. Kanagy NL. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol. 1997;273:H2756-H2764.
33. Turkstra E, Braam B, Koomans HA. Losartan attenuates modest but not strong renal vasoconstriction induced by nitric oxide inhibition. J Cardiovasc Pharmacol. 1998;32:593-600.
34. Blanchard KL, Acquaviva AM, Galson DL, et al. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol. 1992;12:5373-5385.
35. Le MV, Grosse B, Lieberherr M. Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem. 1997;272:11902-11907.